# Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

> **NCT00001350** · — · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1200 (estimated)

## Conditions studied

- Benign Lymphoproliferative Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00001350
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 1993-05-13
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001350, "Study of Autoimmune Lymphoproliferative Syndrome (ALPS)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00001350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*